The outcome of dGTP starvation experiments for cultures initiated at decreasing cell densities. by Mark Itsko (561769)

Inhibition of respiratory chain complex IV activity decreased mitochondrial membrane potential. by Rui Huang (141490)

Inhibition of SKI-1/S1P enzymatic activity using PF-429242 impairs activation of the SREBP pathway and correlates with a dramatic decrease in lipid droplet number and area. by Anastasia Hyrina (3860455)

Inhibition of <i>de novo</i> lipogenesis decreases intracellular HCV RNA. by Sowmya Narayanan (2826308)

Cellular stress decreases TDP-43 levels in patient neurons with the TDP-43 A90V mutation. by Zhijun Zhang (315079)

Subjects:

Chronic CXCL12 production decreased migrationpotential and increased cell:substrate adhesion. by Ishan Roy (530438)

EphA4 immunostaining is decreased adjacent to injury site in ephrin-A5-Fc treated mice. by Yona Goldshmit (205708)

“…<p>Immunohistochemical analysis of (A,B) GFAP, (C–F) EphA4 and (G,H) CSPG expression at 2 weeks after spinal cord hemisection and 2 weeks of ephrin-A5-Fc treatment indicated that there was robust GFAP staining in both treated and control mice (A,B). …”

TBC1D3 selectively decreases IRS-1 Serine phosphorylation. by Marisa J. Wainszelbaum (305403)

UPLC-DAD profile (270 nm) of phytocannabinoids in the extracts separated in C18 column. by Bruno Musetti (9527085)

WFS1 deficiency decreases mitochondrial membrane potential and cytosolic ATP level. by Michal Cagalinec (3151077)

“…Values shown are corrected by subtracting the values obtained in the presence of FCCP incubation (5 μM). The red to green fluorescence ratio demonstrated a slight but significant decrease in the <i>Wfs1</i> siRNA group. …”

CGRP decreases LPS-induced IL-1β mRNA levels. by Aichurek Soultanova (3219459)

miR-181b overexpression decreases cell mitochondrial membrane potential. by Samira Ghorbani (3843895)

WFA induces vimentin degradation and vimentin knockdown decreases cells' sensitivity to WFA. by Guy Lahat (250220)

“…<p><i>A)</i> WFA treatment (5 µM/4 h) results in decreased full-length (FL) vimentin levels and increased expression of vimentin degradation products (VDP) in all STS cells tested. …”

Mutation of stathmin phosphorylation sites decreases sensitivity to bortezomib and influences tubulin polymerization. by Feng Ge (64593)

Decrease of junctional zone area in low protein placentas at E10.5, E17.5 and E18.5. by Paula N. Gonzalez (372538)

Concentrations of particles that caused significant decreases in the viability of SNU-1 cells compared to untreated cells during 1, 2, 4, 6 or 24 h treatment periods. by Amrita Banerjee (382658)

Calcineurin acts as a Ca²⁺ sensor for metamodulation of LP I_h in 5nM DA. by Wulf-Dieter C. Krenz (693267)

“…Experiments were performed as described for <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0117965#pone.0117965.g005" target="_blank">Fig. 5</a> using the calcineurin inhibitor, FK506. …”

PD153035 does not decrease mitochondrial Ca²⁺ uptake, nor prevent permeability transition. by Renata A. Cavalheiro (364722)

Decreased proliferation in <i>AnxA2</i>kd and <i>AnxA5</i>kd cells. by Damian C. Genetos (325684)

VEGFR2/VEGF-A ligand binding decreased ranibizumab and aflibercept mediated CCL2, CCL5, and CX3CL1 mRNA and protein levels in HCAECs. by Clare Arnott (2557705)